ASCO to shine light on multimodal AI models: Plus, melanoma diagnostics and gastroesophageal cancer targets
Dr. Lu will highlight recent work using specimens from the NRG B-20 trial, in which investigators applied multimodal AI appro [...]
Balancing survival and quality of life: The evolving role of AI-enabled pathology in personalized cancer care
Traditional oncology metrics have long measured success in survival curves and hazard ratios, not in days spent comfortably w [...]
Reimagining Cancer Care: The Role of Artificial Intelligence in Clinical Delivery – Eliezer Van Allen
Eliezer Van Allen discusses his keynote address on artificial intelligence in cancer care, describing the transition from sta [...]
OpenAI, Anthropic Shake Up Digital-Health Sector With Their Own Contenders
The arrival of OpenAI and Anthropic in healthcare promises to jolt the sector, threatening some startups as it creates opport [...]
5 ways AI could save cancer patients money
For patients, the price of cancer testing and treatment can add more stress to an already difficult journey. As AI begins to [...]
Did my prostate cancer screening do more harm than good?
In 2002, at age 55, I underwent my first digital rectal exam. The routine check set me on a 15-year path that transformed me [...]
Can Digital Pathology Improve Risk Stratification After Prostatectomy?
A study published in European Urology describes the development and validation of a multimodal artificial intelligence (AI)–d [...]
Cancer survival rates reach record high, but deadliest types still put Americans at risk
People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer S [...]
Meet the Women Leading the AI Industry: Amanda Lowe of Artera
Amanda Lowe, a recognized leader in digital pathology and artificial intelligence, serves as the Chief Commercial Officer at [...]